Update on chronic myeloid leukemia
Review of the work
Chronic Myeloid Leukemia (CML) is a tumor disease produced by the BCR-ABL1 protein kinase produced by the Philadelphia Chromosome, a translocation between chromosome 9 and chromosome 22. The diagnosis of this disease has evolved along with the development of from molecular biology, going from diagnosis by direct observation under the microscope to genetic and molecular techniques. The prognosis of the disease has improved greatly in recent years thanks to the development of BCR-ABL1 Tyrosine Kinase Inhibitors (ITK), leaving the transplantation of hematopoietic progenitors for advanced cases.
Rubio Lacambra, Laura. Graduated in Medicine and Surgery from the University of Malaga in 2014. From 2015-2019 I did the specialty of Hematology and Hemotherapy at the Jaén Hospital Complex. Master in Biotechnology and Biomedicine from the University of Jaén specializing in Biomedicine 2019. Currently I am a Specialist Physician in the Hematology and Hemotherapy Area at the Hospital Comarcal de la Axarquía.